Omeros Corporation
(NASDAQ : OMER)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.69%342.851.2%$619.74m
GILDGilead Sciences, Inc.
-0.78%72.350.9%$506.72m
CELGCelgene Corporation
-0.48%89.941.2%$494.04m
AMGNAmgen Inc.
-0.17%197.091.2%$484.53m
ILMNIllumina, Inc.
0.13%326.303.5%$374.18m
REGNRegeneron Pharmaceuticals, Inc.
-0.53%372.282.6%$314.11m
VRTXVertex Pharmaceuticals Incorporated
-1.06%174.221.9%$206.87m
ALXNAlexion Pharmaceuticals, Inc.
0.07%116.082.0%$186.71m
AAgilent Technologies, Inc.
0.11%64.731.5%$159.45m
SRPTSarepta Therapeutics, Inc.
-0.43%129.6916.6%$141.85m
NKTRNektar Therapeutics
0.23%60.175.6%$126.58m
BLUEBluebird Bio, Inc.
-0.29%157.5514.6%$121.23m
EXASExact Sciences Corporation
-0.85%48.4325.3%$117.82m
BMRNBioMarin Pharmaceutical Inc.
-2.17%98.824.4%$116.17m
INCYIncyte Corporation
-0.39%68.532.5%$111.30m

Company Profile

Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.